Mobile Prenatal Education for Expectant Fathers and Its Effects on Bonding, Stress, Breastfeeding and Marital Satisfaction

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age19-65
SponsorGaziantep Islam Science and Technology University

About this trial

The aim of this interventional clinical trial is to assess whether a mobile-based antenatal education programme for expectant fathers has a positive effect on father-infant bonding, stress levels, and breastfeeding attitudes.

The study aims to answer the following main questions:

Does participation in a mobile-based prenatal education programme strengthen fathers' emotional bonds with their babies? Does the education reduce fathers' stress levels during the prenatal and postnatal periods? Does it increase the father's knowledge and supportive attitude towards breastfeeding? Researchers will compare whether there are measurable differences in attachment, stress, and breastfeeding attitudes between the intervention group (fathers receiving mobile-based education) and the control group (fathers receiving standard routine information).

Participants: Will complete pre- and post-intervention questionnaires assessing attachment, stress, and breastfeeding attitudes.

The intervention group will have access to a six-module mobile application covering topics such as infant care, nutrition, sleep routines, health and safety, emotional development, and daily care practices.

The study will be conducted with fathers aged 19-65 who became fathers within the last month and voluntarily agreed to participate.

Eligibility criteria

Qualifiers

Age between 19 and 65 years

First-time father

Has become a father within the last month

Has a healthy newborn without congenital anomalies or chronic illnesses

Disqualifiers

Declines to participate in the research

Does not own a smartphone

Cannot use mobile applications

Has a physical or mental condition that prevents completing the questionnaires

Trial design

Treatments tested in this trial

  • Mobile-based application

Treatment groups

80 Participants
are divided into 2 treatment groups